NCT02981914 2024-04-22
Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
University of Chicago
Phase EARLY_PHASE1 Completed
University of Chicago
Merck Sharp & Dohme LLC
Icahn School of Medicine at Mount Sinai